Trial · NCT03583697
Adverse events54
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 54
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Rhinitis | Infections and infestations | Placebo | 0 | 32 | 0 |
| other | Rhinitis | Infections and infestations | Vosoritide | 4 | 43 | 8 |
| other | Viral upper respiratory tract infection | Infections and infestations | Placebo | 0 | 32 | 0 |
| other | Viral upper respiratory tract infection | Infections and infestations | Vosoritide | 3 | 43 | 3 |
| other | Lower respiratory tract infection | Infections and infestations | Placebo | 1 | 32 | 3 |
| other | Lower respiratory tract infection | Infections and infestations | Vosoritide | 4 | 43 | 4 |
| other | Viral infection | Infections and infestations | Placebo | 4 | 32 | 8 |
| other | Viral infection | Infections and infestations | Vosoritide | 8 | 43 | 28 |
| other | Injection site reaction | General disorders | Placebo | 13 | 32 | 154 |
| other | Injection site reaction | General disorders | Vosoritide | 34 | 43 | 3,057 |
| other | Injection site erythema | General disorders | Placebo | 13 | 32 | 1,738 |
| other | Injection site erythema | General disorders | Vosoritide | 33 | 43 | 5,100 |
| other | Injection site swelling | General disorders | Placebo | 2 | 32 | 3 |
| other | Injection site swelling | General disorders | Vosoritide | 8 | 43 | 36 |
| other | Injection site induration | General disorders | Placebo | 0 | 32 | 0 |
| other | Injection site induration | General disorders | Vosoritide | 5 | 43 | 14 |
| other | Injection site urticaria | General disorders | Placebo | 1 | 32 | 1 |
| other | Injection site urticaria | General disorders | Vosoritide | 6 | 43 | 22 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 32 | 0 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Vosoritide | 3 | 43 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03583697/events